Today: 19 July 2026
Browse Category

NYSE:BAX 10 August 2025 - 30 April 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Baxter International Stock Jumps After Earnings Beat, But Novum Pump Risk Still Hangs Over 2026

Baxter International Stock Jumps After Earnings Beat, But Novum Pump Risk Still Hangs Over 2026

Baxter International Inc. shares climbed Thursday, bouncing back after the company topped Wall Street’s first-quarter projections and stuck with its annual outlook. The medical products maker reported adjusted earnings of 36 cents a share on $2.70 billion in revenue, clearing LSEG’s bar of 31 cents and $2.62 billion. Product and margin worries had weighed on the stock prior to the results.
30 April 2026
··
Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter’s Q3 showed a mixed picture. Revenue from continuing operations rose about 5% year-over-year to $2.84 billion, helped by strong performance in its Pharmaceuticals and Healthcare Systems unitsbaxter.combaxter.com. However, sales fell short of the street’s ~$2.88 billion estimatereuters.com. On profit, Baxter earned an adjusted $0.69 per share, well above the ~$0.60 expectedreuters.comchartmill.com.
30 October 2025
·
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

This weekend brought a flurry of significant biotech, pharmaceutical, medical, and health developments worldwide – from game-changing scientific breakthroughs to high-stakes regulatory decisions and industry shake-ups. Below is a comprehensive roundup of the major news from August 9 and 10, 2025, organized by category for easy reading.
10 August 2025
······
Go toTop